Boston Scientific Introduces First iPad® App for Physicians to Educate Patients About Cardiovascular Diseases and Treatments

Boston Scientific Corporation (NYSE: BSX) introduces its CardioTeach™ iPad® app, an industry-first, free educational resource to help healthcare professionals better educate patients and caregivers about therapy options related to cardiovascular and peripheral diseases, specifically atrial and ventricular arrhythmias, coronary artery disease, heart failure, heart rhythm disorders and peripheral vascular disease.

CardioTeach provides an overview of normal heart function and common coronary, rhythm and peripheral vascular conditions.  Graphics and easy-to-understand content enable a healthcare provider to effectively explain specific disease states and review available treatments and procedures with patients and their families, enabling them to make more informed decisions about their health.

CardioTeach’s easy-to-use features allow physicians to:

  • Customize and annotate anatomical illustrations
  • Overlay cardiac devices, such as pacemakers and lead wires, onto anatomical illustrations
  • Add notes for emphasis, clarification or personalization
  • Email completed graphics and information to patients, caregivers or other healthcare professionals


“Most medical device apps are designed to educate physicians on a specific product or therapy.  CardioTeach is unique because it lets clinicians better educate patients about their overall heart and vascular health and available treatment options,” said Leslie Saxon, M.D., Chief of Cardiovascular Medicine at University of Southern California.  “I like CardioTeach because it allows patients to have something they can reference after they leave my office and when thinking about or explaining what went on during the office visit.  It also allows my patients and families to educate themselves prior to and between visits.”

“A recent study shows that one in five physicians use a tablet computer in their practice.  Creating an app that enables healthcare professionals to use this technology to enhance communication with patients and caregivers is a logical extension of our efforts to empower patients with information about Boston Scientific’s therapies,” said Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management for Boston Scientific.  “As part of our commitment to patient education, Boston Scientific designed this comprehensive app to be available at no charge in the Apple App Store.”

“Boston Scientific is an industry leader in the deployment of iPads to its U.S. sales force,” said Rich Adduci, Senior Vice President and Chief Information Officer for Boston Scientific.  “In August, the Company launched its Neuromodulation Learning Institute™ app, the industry’s first educational resource for healthcare providers using spinal cord stimulation to manage chronic pain suffered by their patients.  Today’s announcement further demonstrates our dedication to using innovative technologies in new ways to deliver leading-edge information and services to healthcare customers and their patients.”

Visit for additional information about CardioTeach™ for the iPad®.

Source: Boston Scientific